On the recordDecember 12, 2019
Mr. Chairman, I stand here in strong support of Ms. Scanlon's amendment to H.R. 3 and in strong support of H.R. 3, as well. I can say, as a freshman Member of this delegation and this Congress, the number one thing that all of our constituents ask of us each and every day is to address this issue of prescription drug pricing and transparency into that process. This bill and the underlying amendment therein support and affirm both those things. I urge my colleagues on both sides of the aisle to support this bill and its underlying amendment. Mr. Chairman, I yield back the balance of my time.
